SAShahin Ayazi

Shahin Ayazi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shahin Ayazi has a total of 279 co-authors. Here are the top co-authors by number of shared publications:

  • Ping Zheng

    40 shared publications
  • Tom R. DeMeester

    From the Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles

    39 shared publications
  • Arzu Oezcelik

    Division of Thoracic Foregut Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    32 shared publications
  • John C. Lipham

    Division of Upper GI and General Surgery, Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, USA

    27 shared publications
  • Jeffrey A. Hagen

    Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA

    24 shared publications
  • Steven R. DeMeester

    Foregut and Minimally Invasive Surgery, The Oregon Clinic, Portland, OR

    24 shared publications

Latest Publications

  • Open Access

    Serial Assessment of Esophageal Acid Exposure After Nissen Fundoplication and Magnetic Sphincter Augmentation in Patients with Anatomically Intact Repairs

    by Inanc S. Sarici, Sven E. Eriksson, Margaret Gardner, Arjun Guthal, Ahmed E. Aly, Vineeth R. Sadda, Ping Zheng, Shahin Ayazi

  • Open Access

    Beyond the esophagus: Barrett’s esophagus surveillance and colorectal cancer screening

    by Vineeth Sadda, Tara Zarrineh, Ping Zheng, Shahin Ayazi

  • Open Access

    Long-term objective hiatal hernia recurrence after magnetic sphincter augmentation versus laparoscopic fundoplication: a multicenter cohort study of moderate and large hiatal hernias

    by Shahin Ayazi, F. P. Buckley, John C. Lipham, Philip Woodworth, Mark S. Shachner, Carlos J. Anciano, Vineeth Sadda, Kate Freeman, Rachel Heidrick, Reginald C. W. Bell

    Background: Recurrent hiatal hernia is a leading cause of long-term failure after antireflux surgery and the most common indication for revisional surgery. Although magnetic sphincter augmentation (MSA) has demonstrated favorable outcomes following repair of moderate and large hiatal hernias, its long-term anatomical durability compared with laparoscopic fundoplication remains unclear. We compared the durability of hiatal hernia repair following MSA versus fundoplication in patients with moderate and large hiatal hernias using objective assessment of postoperative hiatal hernia recurrence. Methods: This multicenter observational cohort study analyzed prospectively maintained registries from six high-volume foregut centers. Adult patients undergoing primary repair of moderate (3–5 cm) or large (> 5 cm or paraesophageal) hiatal hernias with MSA or laparoscopic fundoplication who underwent protocol-directed objective follow-up 3 years after surgery were included. The primary outcome was objective hiatal hernia recurrence. Secondary outcomes included GERD-HRQL, proton pump inhibitor use, patient satisfaction, and revisional surgery. Results: A total of 258 patients underwent antireflux surgery, including 196 (76.0%) treated with MSA and 62 (24.0%) with fundoplication. At 3 years, objective hiatal hernia recurrence was significantly lower following MSA than fundoplication (6.1% vs 21.0%; P = 0.002). On multivariable analysis, fundoplication was significantly associated with 3-year objective hiatal hernia recurrence (OR, 4.67; 95% CI, 1.11–19.59; P = 0.035). Despite lower recurrence after MSA, GERD-HRQL, dysphagia, bloating, patient satisfaction, and revisional surgery rates were similar between groups, whereas postoperative proton pump inhibitor use was lower following MSA (11.5% vs 27.5%; P = 0.022). Conclusions: MSA was associated with lower objective hiatal hernia recurrence than laparoscopic fundoplication, but patient-reported outcomes were similar between procedure groups. Long-term anatomical durability should be considered alongside patient-reported outcomes when selecting the optimal antireflux procedure.

  • Open Access

    Proton pump inhibitor use after kidney transplantation and graft outcomes

    by Ahmed E. Aly, Vineeth R. Sadda, Emma Venard, Tasneem Ekhtiar, Colin Powers, Sharon L. Darby, Ping Zheng, Shahin Ayazi

    This study evaluates the impact of proton pump inhibitor (PPI) use on graft-related outcomes following renal transplant. Proton pump inhibitors (PPIs) are frequently continued after kidney transplantation, often without a clear ongoing indication. Although their use has been associated with adverse renal outcomes in non-transplant populations, their clinical relevance in transplant recipients remains uncertain. We performed a retrospective cohort study using the TriNetX database of US health networks. We included 23,306 patients from 2000–2021 enrolled 4–6 weeks following their transplant. Patients were stratified by post-transplant PPI use and propensity score matched. The primary outcome was graft survival over 5 years; secondary outcomes included need for dialysis, renal function, and re-transplantation. Among 23,306 recipients, 15,601 patients (66.9%) were on PPI therapy 1 month post-transplant; 7553 matched pairs were analyzed. Post-transplant PPI use was associated with increased graft failure within 1 year (16.8% vs 9.4%; HR 1.79 [1.59–2.01]; P < .001) and between 1 and 5 years (12.8% vs 4.7%; HR 2.63 [2.27–3.05]; P < .001). Survival curves demonstrated early and sustained separation through 5 years (72.6% vs 85.8%; log-rank test P < .001). PPI exposure was also associated with increased dialysis dependence, progressive decline in graft function, and repeat transplantation, with greater risk observed with prolonged use (all P < .001). Post-transplant PPI use was common among kidney transplant recipients and was associated with a significantly increased risk of graft failure and worse kidney transplant outcomes. Persistent PPI use after kidney transplantation may represent a modifiable aspect of care, supporting periodic reassessment of acid suppression in transplant recipients.

  • Open Access

    Impact of hypercontractile esophagus on clinical and physiologic outcomes after antireflux surgery: a matched-control study

    by Emma Venard, Vineeth R. Sadda, Ahmed E. Aly, Tasneem Ekhtiar, Adam Ernst, Tara Zarrineh, Sarah Hanuschock, Ping Zheng, Shahin Ayazi

  • Open Access

    Blown-out myotomy: one radiographic phenotype, multiple biologic pathways

    by Shahin Ayazi, John C. Lipham, John G. Hunter

  • Open Access

    Association between mesh reinforcement and postoperative gastroparesis following paraesophageal and hiatal hernia repair: a propensity-matched analysis

    by Ahmed E. Aly, Rhea Verma, Naqeeb Faroqui, Vineeth R. Sadda, Joey Woodrow, Ping Zheng, Shahin Ayazi

    Background: Mesh reinforcement during hiatal hernia repair, including paraesophageal hernia repair, remains controversial because of uncertain long-term durability benefits and concerns regarding mesh-related complications. Its association with postoperative gastric dysmotility remains poorly defined. We evaluated the association between mesh reinforcement and new-onset gastroparesis following hiatal hernia repair. Methods: Adults undergoing repair of a hiatal hernia between 2013 and 2023 were identified from a multi-institutional U.S. database and stratified by mesh utilization. Patients with preexisting gastroparesis or prior prokinetic medication use were excluded. The primary outcome was new-onset gastroparesis diagnosed between 1 month and 1 year postoperatively. Secondary outcomes included initiation of prokinetic medications, gastroparesis-related symptoms, and subsequent interventions for gastric dysmotility. Propensity score matching was performed to balance demographic and clinical characteristics. Prespecified subgroup analyses evaluated obesity, diabetes, and revisional repair. Results: A total of 29,923 patients were identified, of whom 10,010 (33.5%) underwent mesh-reinforced repair. After propensity matching, mesh reinforcement was associated with a higher incidence of postoperative gastroparesis compared with non-mesh repair (2.04% vs 1.51%; OR 1.36, p = 0.011). The association was more pronounced in patients with obesity, including those with BMI > 30 (2.52% vs 1.53%; OR 1.68, p = 0.013), with the strongest effect observed in patients with BMI > 35 (2.64% vs 0.84%; OR 3.24, p < 0.001). Rates of postoperative prokinetic use, gastroparesis-related symptoms, and subsequent interventions for gastric dysmotility were similar between groups. Among patients undergoing mesh-reinforced repair, revisional operations were associated with higher rates of postoperative gastroparesis than primary repairs after matching (4.32% vs 1.93%; OR 2.31, p = 0.004). Conclusion: Mesh reinforcement during hiatal hernia repair was associated with a modest increase in the risk of postoperative gastroparesis, although the absolute risk remained low and there were no corresponding differences in symptom burden. The association was most pronounced among patients with severe obesity, while revisional mesh-reinforced repairs had the highest incidence of postoperative gastroparesis. These findings suggest that patient susceptibility and operative complexity may contribute to postoperative gastric dysmotility in addition to mesh utilization.

  • Open Access

    Lyon Consensus 2.0 vs Conventional Surgical Criteria for Predicting Favorable Outcomes After Antireflux Surgery

    by Sven E Eriksson, Vineeth Sadda, Ahmed Aly, Tasneem Ekhtiar, Inanc S Sarici, Ping Zheng, Shahin Ayazi

    Background: Lyon Consensus 2.0 revised the criteria for conclusive GERD by including grade B esophagitis and requiring abnormal acid exposure on at least 2 monitoring days for physiologic confirmation. Whether these criteria improve selection of patients for antireflux surgery (ARS) remains uncertain. We compared Lyon 2.0 with conventional surgical criteria for their association with favorable postoperative outcomes. Study Design: Patients undergoing ARS after preoperative endoscopy and 48-hour wireless pH monitoring were classified according to Lyon 2.0 criteria and conventional surgical criteria, defined as grade C/D esophagitis or an abnormal DeMeester score on ≥1 monitoring day. Favorable outcome was defined as patient satisfaction and freedom from proton pump inhibitor use at 1 year. Associations were evaluated using multivariable logistic regression, receiver operating characteristic analysis, and decision curve analysis. Results: Among 1,068 patients, 76.7% achieved a favorable outcome. Conventional surgical criteria were associated with favorable outcomes (adjusted odds ratio 1.93; p=0.006). Patients meeting both frameworks had the highest favorable outcome rate (79.7%). However, 26.1% met conventional surgical criteria but not Lyon 2.0 criteria, and 73.1% of these patients achieved a favorable outcome. Discrimination did not differ significantly between Lyon 2.0 and conventional criteria (area under the curve 0.571 vs 0.558; p=0.469). Conclusions: Lyon 2.0 and conventional surgical criteria identify overlapping but distinct ARS populations. Nearly three-quarters of patients meeting conventional criteria but not Lyon 2.0 achieved a favorable outcome. Failure to meet Lyon 2.0 criteria alone should not be used to exclude patients from operative consideration.

  • Open Access

    Gastroparesis in heart failure: temporal trends, clinical correlates, and outcomes in a large national cohort

    by Vineeth Sadda, Naveed Chaudhry, Himsikhar Khataniar, Ping Zheng, Shahin Ayazi

    Gastrointestinal complications of heart failure are increasingly recognized, but the epidemiology and clinical significance of gastroparesis in this population remain poorly defined. We evaluated a national multicenter cohort of adults with heart failure to characterize temporal trends in gastroparesis incidence, identify factors associated with its development, and assess its association with clinical outcomes. We used a national multicenter database to identify adults diagnosed with heart failure from 2005 to 2025. Temporal trends in gastroparesis incidence were evaluated at 5-year intervals, multivariable Cox proportional hazards regression was used to identify factors associated with its development, and 5-year cardiorenal and healthcare utilization outcomes were compared between patients with and without gastroparesis. Among 3,913,826 patients with heart failure, gastroparesis incidence increased more than tenfold during the study period, from 35.6 to 402.3 cases per 100,000 person-years. Diabetes mellitus [hazard ratio (HR) =4.54], chronic mesenteric ischemia (HR =2.16), ascites (HR =1.55), and heart failure with preserved ejection fraction (HR =1.60) were independently associated with gastroparesis. Patients with concomitant gastroparesis experienced significantly higher risks of major adverse cardiovascular events (MACE) [31.8% vs. 19.7%; odds ratio (OR) =1.90; 95% confidence interval (CI): 1.80–1.99; Pvs. 22.6%; OR =2.19; 95% CI: 2.11–2.27; P<0.001). These findings identify gastroparesis as an increasingly recognized comorbidity in patients with heart failure that may represent a high-risk phenotype. The observed associations further suggest that venous congestion and impaired splanchnic perfusion may contribute to the development of gastric dysmotility in this population.

  • Development and Reliability of a Competency Assessment Tool for Magnetic Sphincter Augmentation of the Esophagus (MSA CAT) as Part of a Video-based Surgical Quality Assurance Program for the GOLF Trial

    by Nainika Menon, Paul Goldsmith, Richard Owen, Heidi Paine, Maria Bencivenga, Luigi Bonavina, James Gossage, Christian A. Gutschow, Sumeet Mittal, Jessica M. Leers, et al.

    Objective: The development and reliability testing of a video-based competency assessment tool for magnetic sphincter augmentation of the esophagus (MSA CAT). Summary Background Data: Surgical quality assurance (SQA) is the assessment of intraoperative performance by measuring adherence to standardized steps, occurrence of technical errors, and overall technical proficiency. SQA is part of the GOLF trial (ISRCTN: 1353317), an international, multicenter randomized controlled trial (RCT) comparing 2 antireflux procedures, magnetic sphincter augmentation (MSA) and fundoplication. GOLF is the first RCT in which a video-based SQA program was developed with a plan for validation and implementation. Methods: Ten international experts in antireflux surgery participated in a 3-round virtual Delphi consensus process to develop the MSA CAT. To establish interassessor reliability, 6 surgeons reviewed 2 MSA videos. After 3 months, they reviewed the same MSA videos to test intra-assessor reliability using Cohen’s kappa coefficient. Results: Operative steps and key errors were drafted based on the literature. During the 3-round virtual Delphi Consensus amendments to each version were undertaken. Finally, an operative manual and CAT were developed with mandatory, optional, and prohibited steps and quality scores ranging from 1 to 4. The MSA CAT demonstrated good inter- and intra-assessor reliability, particularly when categorizing pairs of scores into “concerning” versus “acceptable.” For interassessor reliability, the mean Cohen’s kappa was 0.785 (0.582–0.892) and 0.827 (0.591–0.912) for each video. For intra-assessor reliability, it was 0.745 (0.717–0.773) and 0.740 (0.510–1.00) for each video. Discussion: This work describes the development and reliability of the novel MSA CAT. This will be further validated by prospective and retrospective video analysis.